1. Home
  2. ENVB vs AIHS Comparison

ENVB vs AIHS Comparison

Compare ENVB & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • AIHS
  • Stock Information
  • Founded
  • ENVB 1994
  • AIHS 2014
  • Country
  • ENVB United States
  • AIHS China
  • Employees
  • ENVB N/A
  • AIHS N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • ENVB Health Care
  • AIHS Finance
  • Exchange
  • ENVB Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • ENVB 3.0M
  • AIHS 3.0M
  • IPO Year
  • ENVB N/A
  • AIHS 2018
  • Fundamental
  • Price
  • ENVB $0.97
  • AIHS $2.14
  • Analyst Decision
  • ENVB Strong Buy
  • AIHS
  • Analyst Count
  • ENVB 1
  • AIHS 0
  • Target Price
  • ENVB $10.00
  • AIHS N/A
  • AVG Volume (30 Days)
  • ENVB 325.7K
  • AIHS 9.0M
  • Earning Date
  • ENVB 08-14-2025
  • AIHS 08-19-2025
  • Dividend Yield
  • ENVB N/A
  • AIHS N/A
  • EPS Growth
  • ENVB N/A
  • AIHS N/A
  • EPS
  • ENVB N/A
  • AIHS N/A
  • Revenue
  • ENVB N/A
  • AIHS $3,370,162.00
  • Revenue This Year
  • ENVB N/A
  • AIHS N/A
  • Revenue Next Year
  • ENVB N/A
  • AIHS N/A
  • P/E Ratio
  • ENVB N/A
  • AIHS N/A
  • Revenue Growth
  • ENVB N/A
  • AIHS 8.56
  • 52 Week Low
  • ENVB $0.85
  • AIHS $1.84
  • 52 Week High
  • ENVB $8.33
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 40.51
  • AIHS 44.27
  • Support Level
  • ENVB $0.85
  • AIHS $2.08
  • Resistance Level
  • ENVB $1.06
  • AIHS $8.26
  • Average True Range (ATR)
  • ENVB 0.10
  • AIHS 0.72
  • MACD
  • ENVB -0.02
  • AIHS 0.00
  • Stochastic Oscillator
  • ENVB 19.34
  • AIHS 1.61

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: